Enabling sustainable supply of the essential cancer medicines etoposide and teniposide in yeast
Science · 30.07.2026 · 393 (6810)
DOI: 10.1126/science.aef5438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 30.07.2026. Verfasst von Siyu Shen und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Phytogenic, Etoposide, Podophyllotoxin, Saccharomyces cerevisiae. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Beijing Municipal Natural Science Foundation, The National Key Research and Development Program of China, Chinese Institutes for Medical Research Beijing.
Abstract (Originalsprache)
Lignans constitute a diverse family of plant metabolites with therapeutic potential. Among them, podophyllotoxin-type aryltetralin lignans serve as precursors for etoposide and teniposide. Etoposide is an essential anticancer medicine approved for first-line treatment of small cell lung cancer, whereas teniposide is used for treatment of leukemia and some brain tumors. Currently, these drugs depend on extraction of precursors from the endangered plant Sinopodophyllum hexandrum , followed by chemical transformations. By identifying key glycosyltransferases and executing more than 60 genetic edits involving 45 heterologous enzymes, the complex biosynthetic pathway of podophyllotoxin-type lignans was reconstructed in yeast. In this study, we established a chemoenzymatic route that streamlines the synthesis of etoposide and teniposide through a single chemical step from biosynthetic precursor 4′-demethyl-epipodophyllotoxin-4 -O- glucoside, which enables a secure supply chain of these essential medicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
- State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
- School of Pharmaceutical Sciences, Capital Medical University, Beijing, China.
- Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
- BioInnovation Institute, Copenhagen, Denmark.
ORCID-Profile: Siyu Shen, Xue Hu, Dan Li, Yuru Tong, Yunpeng Lv, Zhenjiang Tian, Jiadian Wang, Yapeng Wang, Lan Kang, Jens Nielsen, Luqi Huang, Yating Hu
Förderung
- Beijing Municipal Natural Science Foundation
- The National Key Research and Development Program of China
- Chinese Institutes for Medical Research Beijing
- the Key Project at the central government level: the ability establishment of sustainable use for valuable Chinese medicine resources
Zitieren
APA
Shen, S., Hu, X., Li, D., Tong, Y., Lv, Y., Tian, Z., Wang, J., Tang, H., Wang, Y., Kang, L., Nielsen, J., Huang, L., & Hu, Y. (2026). Enabling sustainable supply of the essential cancer medicines etoposide and teniposide in yeast. Science, 393(6810). https://doi.org/10.1126/science.aef5438
Vancouver
Shen S, Hu X, Li D, Tong Y, Lv Y, Tian Z, et al. Enabling sustainable supply of the essential cancer medicines etoposide and teniposide in yeast. Science. 2026;393(6810). doi:10.1126/science.aef5438
BibTeX
@article{Shen2026,
author = {Shen, Siyu and Hu, Xue and Li, Dan and Tong, Yuru and Lv, Yunpeng and Tian, Zhenjiang and Wang, Jiadian and Tang, Hao and Wang, Yapeng and Kang, Lan and Nielsen, Jens and Huang, Luqi and Hu, Yating},
title = {Enabling sustainable supply of the essential cancer medicines etoposide and teniposide in yeast},
journal = {Science},
year = {2026},
volume = {393},
number = {6810},
doi = {10.1126/science.aef5438}
}
EUVIMED